Pharming (PHAR) Return on Assets (2021 - 2025)
Historic Return on Assets for Pharming (PHAR) over the last 5 years, with Q3 2025 value amounting to 0.05%.
- Pharming's Return on Assets rose 1600.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.03% for FY2024, which is 200.0% down from last year.
- Per Pharming's latest filing, its Return on Assets stood at 0.05% for Q3 2025, which was up 1600.0% from 0.01% recorded in Q2 2025.
- Over the past 5 years, Pharming's Return on Assets peaked at 0.14% during Q1 2022, and registered a low of 0.11% during Q2 2024.
- In the last 5 years, Pharming's Return on Assets had a median value of 0.0% in 2021 and averaged 0.0%.
- As far as peak fluctuations go, Pharming's Return on Assets tumbled by -1700bps in 2024, and later skyrocketed by 1600bps in 2025.
- Pharming's Return on Assets (Quarter) stood at 0.11% in 2021, then crashed by -100bps to 0.0% in 2022, then crashed by -22888bps to 0.05% in 2023, then plummeted by -122bps to 0.1% in 2024, then skyrocketed by 152bps to 0.05% in 2025.
- Its last three reported values are 0.05% in Q3 2025, 0.01% for Q2 2025, and 0.06% during Q1 2025.